PI3K/AKT signaling is involved in CRC, with a frequency of 15–20%, and can be mediated by miR-126, which mediates a reduction in p85β followed by a reduction in phosphorylated AKT levels in cancer cells, suggesting a deficiency in PI3K signaling [111,112]. The gene discussed is AKT1; the disease is cancer.